Package | smart.who.int.immunizations |
Resource Type | PlanDefinition |
Id | IMMZD2DTPolioSequential |
FHIR Version | R4 |
Source | http://smart.who.int/immunizations/https://build.fhir.org/ig/WorldHealthOrganization/smart-immunizations/PlanDefinition-IMMZD2DTPolioSequential.html |
URL | http://smart.who.int/immunizations/PlanDefinition/IMMZD2DTPolioSequential |
Version | 0.2.0 |
Status | draft |
Date | 2025-08-08T19:12:11+00:00 |
Name | IMMZD2DTPolioSequential |
Title | IMMZ.D2.DT.Polio.Sequential IPV–bOPV |
Authority | who |
Description | IMMZ.D2.DT.Polio.Sequential IPV–bOPV Sequential "Bivalent oral polio vaccine (bOPV)–inactivated polio vaccine (IPV)" schedule (in countries with high vaccination coverage [e.g. 90–95%] and low importation risk [where neighbouring countries and/or countries that share substantial population movement have a similarly high coverage]) |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Id: | IMMZD2DTPolioSequential | |||
---|---|---|---|---|
Url: | IMMZ.D2.DT.Polio.Sequential IPV–bOPV | |||
Version: | 0.2.0 | |||
Title: | IMMZ.D2.DT.Polio.Sequential IPV–bOPV | |||
Status: | draft | |||
Type: |
system: http://terminology.hl7.org/CodeSystem/plan-definition-type code: eca-rule |
|||
Date: | 2025-08-08 19:12:11+0000 | |||
Publisher: | WHO | |||
Description: | IMMZ.D2.DT.Polio.Sequential IPV–bOPV Sequential "Bivalent oral polio vaccine (bOPV)–inactivated polio vaccine (IPV)" schedule (in countries with high vaccination coverage [e.g. 90–95%] and low importation risk [where neighbouring countries and/or countries that share substantial population movement have a similarly high coverage]) |
|||
Knowledge Capability: | computable | |||
Related Artifacts: |
References |
|||
Libraries: |
|
|||
Actions: |
|
{ "resourceType": "PlanDefinition", "id": "IMMZD2DTPolioSequential", "meta": { "profile": [ "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition", "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-shareableplandefinition", "http://hl7.org/fhir/uv/crmi/StructureDefinition/crmi-publishableplandefinition" ] }, "text": { "status": "extensions", "div": "<!-- snip (see above) -->" }, "extension": [ { "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability", "valueCode": "computable" } ], "url": "http://smart.who.int/immunizations/PlanDefinition/IMMZD2DTPolioSequential", "version": "0.2.0", "name": "IMMZD2DTPolioSequential", "title": "IMMZ.D2.DT.Polio.Sequential IPV–bOPV", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type", "code": "eca-rule" } ] }, "status": "draft", "experimental": false, "date": "2025-08-08T19:12:11+00:00", "publisher": "WHO", "contact": [ { "name": "WHO", "telecom": [ { "system": "url", "value": "http://who.int" } ] } ], "description": "IMMZ.D2.DT.Polio.Sequential IPV–bOPV\nSequential \"Bivalent oral polio vaccine (bOPV)–inactivated polio vaccine (IPV)\" schedule (in countries with high vaccination coverage [e.g. 90–95%] and low importation risk [where neighbouring countries and/or countries that share substantial population movement have a similarly high coverage])", "relatedArtifact": [ { "type": "citation", "citation": "WHO recommendations for routine immunization - summary tables (January 2025)" } ], "library": [ "http://smart.who.int/immunizations/Library/IMMZD2DTPolioSequentialLogic" ], "action": [ { "extension": [ { "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale", "valueMarkdown": "For sequential IPV– bOPV schedules, WHO recommends that the first dose of IPV be given starting from 8 weeks of \n age with an interval of 4–8 weeks before administration of the second IPV dose. This should be followed by at least 2 doses \n of bOPV separated by 4–8 weeks depending on the risk of exposure to poliovirus in early childhood. Where a sequential IPV–bOPV \n schedule is used, the initial administration of 2 doses of IPV should be followed by ≥2 doses of bOPV to ensure sufficient \n levels of protection in the intestinal mucosa as well as a decrease in the burden of vaccine-associated paralytic polio (VAPP)." } ], "title": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule", "description": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule\nSequential \"Bivalent oral polio vaccine (bOPV)–inactivated polio vaccine (IPV)\" schedule (in countries with high \nvaccination coverage [e.g. 90–95%] and low importation risk [where neighbouring countries and/or countries that share \nsubstantial population movement have a similarly high coverage])", "condition": [ { "kind": "applicability", "expression": { "description": "Client is due for IPV vaccination", "language": "text/cql-identifier", "expression": "Client is due for IPV vaccination" } } ], "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTPolioIPVMR", "dynamicValue": [ { "path": "status", "expression": { "language": "text/cql-expression", "expression": "'draft'" } }, { "path": "intent", "expression": { "language": "text/cql-expression", "expression": "'proposal'" } } ] }, { "extension": [ { "url": "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-rationale", "valueMarkdown": "For sequential IPV– bOPV schedules, WHO recommends that the first dose of IPV be given starting from 8 weeks of \n age with an interval of 4–8 weeks before administration of the second IPV dose. This should be followed by at least 2 doses \n of bOPV separated by 4–8 weeks depending on the risk of exposure to poliovirus in early childhood. Where a sequential IPV–bOPV \n schedule is used, the initial administration of 2 doses of IPV should be followed by ≥2 doses of bOPV to ensure sufficient \n levels of protection in the intestinal mucosa as well as a decrease in the burden of vaccine-associated paralytic polio (VAPP)." } ], "title": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule", "description": "Determine if the client is due for a poliovirus vaccination according to the national immunization schedule\nSequential \"Bivalent oral polio vaccine (bOPV)–inactivated polio vaccine (IPV)\" schedule (in countries with high \nvaccination coverage [e.g. 90–95%] and low importation risk [where neighbouring countries and/or countries that share \nsubstantial population movement have a similarly high coverage])", "condition": [ { "kind": "applicability", "expression": { "description": "Client is due for bOPV vaccination", "language": "text/cql-identifier", "expression": "Client is due for bOPV vaccination" } } ], "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTPolioOPVMR", "dynamicValue": [ { "path": "status", "expression": { "language": "text/cql-expression", "expression": "'draft'" } }, { "path": "intent", "expression": { "language": "text/cql-expression", "expression": "'proposal'" } } ] }, { "title": "Check for Guidance for the patient regarding IMMZ.D2.DT.Polio.Sequential IPV–bOPV.", "description": "Show Guidance for the patient regarding IMMZ.D2.DT.Polio.Sequential IPV–bOPV.", "condition": [ { "kind": "applicability", "expression": { "description": "Has Guidance", "language": "text/cql-identifier", "expression": "Has Guidance" } } ], "definitionCanonical": "http://smart.who.int/immunizations/ActivityDefinition/IMMZD2DTCR", "dynamicValue": [ { "path": "status", "expression": { "language": "text/cql-expression", "expression": "'active'" } }, { "path": "payload.contentString", "expression": { "language": "text/cql-identifier", "expression": "Guidance" } }, { "path": "category.coding", "expression": { "description": "Category of communication", "language": "text/cql-expression", "expression": "Code { system: 'http://terminology.hl7.org/CodeSystem/communication-category', code: 'alert' }" } }, { "path": "priority", "expression": { "description": "Alert priority", "language": "text/cql-expression", "expression": "Code { system: 'http://hl7.org/fhir/request-priority', code: 'routine' }" } } ] } ] }